This signaling pathway, along with migration and invasion, was inhibited in PRL-3 overexpressing gastric cancer cells treated with PI3K inhibitor, confirming that PRL-3 acts upstream of the PI3K-AKT pathway to induce its activation [63]. Here, AKT1 is linked to gastric cancer.